Santos da Silva Jorge 4
4 · MoonLake Immunotherapeutics · Filed Feb 29, 2024
Insider Transaction Report
Form 4
Santos da Silva Jorge
DirectorChief Executive Officer
Transactions
- Sale
Class A ordinary shares, par value $0.0001 per share
2024-02-28$55.00/sh−56,065$3,083,575→ 2,987,554 total - Sale
Class A ordinary shares, par value $0.0001 per share
2024-02-29$55.89/sh−4,740$264,919→ 2,982,814 total - Sale
Class A ordinary shares, par value $0.0001 per share
2024-02-27$55.00/sh−62,810$3,454,550→ 3,043,619 total
Footnotes (2)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 17, 2023.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.50 to $57.55. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.